| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/28/2002 | CA2448186A1 Novel smg-1 |
| 11/28/2002 | CA2448185A1 Method for identifying micro-organisms using mass spectrometry |
| 11/28/2002 | CA2448165A1 Pyruvate-kinase as a novel target molecule |
| 11/28/2002 | CA2448153A1 Means and methods for identifying genes and proteins involved in the prevention and/or repair of a replication error |
| 11/28/2002 | CA2448145A1 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides |
| 11/28/2002 | CA2448142A1 Beta-secretase substrates and uses thereof |
| 11/28/2002 | CA2448125A1 Increasing bioavailability of carotenoids |
| 11/28/2002 | CA2448102A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
| 11/28/2002 | CA2448092A1 Internalisation of virus into cells |
| 11/28/2002 | CA2448018A1 Compositions and methods for inhibiting metastasis |
| 11/28/2002 | CA2448014A1 Tsg101 as inhibitor of hiv production |
| 11/28/2002 | CA2447958A1 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 11/28/2002 | CA2447823A1 Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia |
| 11/28/2002 | CA2447799A1 Emission ratiometric indicators of phosphorylation |
| 11/28/2002 | CA2447680A1 Hevein-binding monoclonal antibodies |
| 11/28/2002 | CA2447612A1 Selection of target sites for antisense attack of rna |
| 11/28/2002 | CA2447357A1 Molecular toxicology modeling |
| 11/28/2002 | CA2447340A1 Kinases and phosphatases |
| 11/28/2002 | CA2447338A1 Receptors and membrane-associated proteins |
| 11/28/2002 | CA2447336A1 Methods of detecting protein arginine methyltransferase, and uses related thereto |
| 11/28/2002 | CA2447231A1 Methods for inhibiting angiogenesis |
| 11/28/2002 | CA2447215A1 Adherent entities and uses therefor |
| 11/28/2002 | CA2447161A1 Conjugates and compositions for cellular delivery |
| 11/28/2002 | CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 11/28/2002 | CA2443342A1 Mage-a3 peptides presented by hla class ii molecules |
| 11/28/2002 | CA2441666A1 Phytases, nucleic acids encoding them and methods and using them |
| 11/27/2002 | WO2001094575A1 Dna sequence regulating plant fruit-specific expression |
| 11/27/2002 | EP1260817A2 Method for direct measurement of coagulation factor VIIa activity in plasma |
| 11/27/2002 | EP1260816A1 Method of examining allergic diseases |
| 11/27/2002 | EP1260597A2 Process for labeling a nucleic acid, including purification, and labeled RNA fragments obtained by this process |
| 11/27/2002 | EP1260596A2 Process for labeling a ribonucleic acid, including optional signal amplification, and labeled RNA fragments which are obtained by this process |
| 11/27/2002 | EP1260595A2 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same |
| 11/27/2002 | EP1260594A2 Arrangement of nucleic acid sequences and use thereof |
| 11/27/2002 | EP1260593A2 Detection of nucleic acids by nuclease-catalyzed product formation |
| 11/27/2002 | EP1260592A1 Biochip |
| 11/27/2002 | EP1260591A1 High-efficiency assay for protein mannosyl transferases |
| 11/27/2002 | EP1260590A1 Method of screening substance specifically inhibiting non-mevalonate pathway |
| 11/27/2002 | EP1260589A2 Biosensor |
| 11/27/2002 | EP1260587A2 Tyrosyl tRNA synthetase |
| 11/27/2002 | EP1260583A1 System and method for manipulating magnetically responsive particles in fluid samples to collect DNA or RNA from a sample |
| 11/27/2002 | EP1260519A1 Membrane receptors for steroids and sterols |
| 11/27/2002 | EP1260228A2 Human growth gene and short stature gene region. Therapeutic uses |
| 11/27/2002 | EP1259928A2 Process for estimating random error in chemical and biological assays |
| 11/27/2002 | EP1259827A2 Biosynthetic carbohydrate-deficient transferrin references |
| 11/27/2002 | EP1259824A1 Trisomy 21 cytotrophoblast cultures, and uses thereof for obtaining trisomy 21 markers |
| 11/27/2002 | EP1259813A2 Diagnosis and treatment of malignant neoplasms |
| 11/27/2002 | EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 11/27/2002 | EP1259808A2 Method for labeling individual cells |
| 11/27/2002 | EP1259800A2 Enzymatic-electrochemical measuring device |
| 11/27/2002 | EP1259650A2 Estrogen receptor alpha variants and methods of detection thereof |
| 11/27/2002 | EP1259649A2 Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions |
| 11/27/2002 | EP1259648A2 Diagnostics and therapeutics for glaucoma |
| 11/27/2002 | EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 11/27/2002 | EP1259646A2 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination |
| 11/27/2002 | EP1259645A1 Universal variable fragments |
| 11/27/2002 | EP1259644A2 Novel dna chips |
| 11/27/2002 | EP1259643A2 Nucleic acid detection methods using universal priming |
| 11/27/2002 | EP1259642A1 Nucleic acids, proteins, and antibodies |
| 11/27/2002 | EP1259641A2 Combinatorial oligonucleotide pcr: a method for rapid, global expression analysis |
| 11/27/2002 | EP1259640A2 Methods and compositions for the screening of cell cycle modulators |
| 11/27/2002 | EP1259639A2 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections |
| 11/27/2002 | EP1259638A2 Methods for selectively modulating survivin apoptosis pathways |
| 11/27/2002 | EP1259637A2 Caspase-inhibitory-factor (cif) and uses thereof |
| 11/27/2002 | EP1259636A2 Method for determining the modulation of nad(p)h oxidoreductase |
| 11/27/2002 | EP1259635A1 Methods of screening for antimicrobial compounds |
| 11/27/2002 | EP1259634A2 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor |
| 11/27/2002 | EP1259627A2 Heterologous expression of neisserial proteins |
| 11/27/2002 | EP1259623A2 Aspartate carbamyltransferase as herbicidal target |
| 11/27/2002 | EP1259621A2 Lipid metabolism enzymes |
| 11/27/2002 | EP1259618A2 Human enzyme molecules |
| 11/27/2002 | EP1259614A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/27/2002 | EP1259612A2 G-protein coupled receptor related polypeptides |
| 11/27/2002 | EP1259611A2 G-protein coupled receptors |
| 11/27/2002 | EP1259609A2 Human schizophrenia gene |
| 11/27/2002 | EP1259606A2 Compositions useful for regulating parkin gene activity |
| 11/27/2002 | EP1259604A1 Bcmp 84, a protein associated to breast cancer |
| 11/27/2002 | EP1259603A2 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 11/27/2002 | EP1259602A1 Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same |
| 11/27/2002 | EP1259599A1 Cell fusion assays using fluorescence resonance energy transfer |
| 11/27/2002 | EP1259597A2 Zinc finger domains and methods of identifying same |
| 11/27/2002 | EP1259595A2 Integrin antagonists |
| 11/27/2002 | EP1259546A1 Ccr2-64i, polymorphic variant of the human ccr2 receptor and its use in the diagnostic and treatment of atherosclerosis |
| 11/27/2002 | EP1259542A2 Reagents and methods useful for detecting diseases of the breast |
| 11/27/2002 | EP1259540A1 Nucleic acids, proteins, and antibodies |
| 11/27/2002 | EP1259531A2 Nucleic acids, proteins, and antibodies |
| 11/27/2002 | EP1259530A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
| 11/27/2002 | EP1259529A2 Thermophilic dna polymerases from thermoactinomyces vulgaris |
| 11/27/2002 | EP1259528A1 Nucleic acids, proteins and antibodies |
| 11/27/2002 | EP1259527A1 35 human secreted proteins |
| 11/27/2002 | EP1259526A2 Nucleic acids, proteins, and antibodies |
| 11/27/2002 | EP1259525A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
| 11/27/2002 | EP1259524A2 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage |
| 11/27/2002 | EP1259324A2 Multiple-site reaction device and method |
| 11/27/2002 | EP1259258A1 Gm-negative ehv-mutants |
| 11/27/2002 | EP1259255A1 Pai-2 conjugates for the treatment and imaging of cancer |
| 11/27/2002 | EP1259249A1 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof |
| 11/27/2002 | EP1259248A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d |
| 11/27/2002 | EP1259232A1 Method for identifying an agent for treatment of niddmdiabetes by interaction with compound u0126 |
| 11/27/2002 | EP1259121A2 Weight loss induced by reduction in neuropeptide y level |
| 11/27/2002 | EP1221954A4 Methods for identifying inhibitors of methionine aminopeptidases |